Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia

Clinical Microbiology and Infection

Volumn 7, Issue 7, 2001, Pages 376-379

  Vogel, F ^a   Ochs, H R ^b   Wettich, K ^c   Kalich, S ^c   Nilsson Ehle, I ^d   Odenholt, I ^d   Nord, C E ^e  

^a Krankenhaus Hofheim   (Germany)

^b Marienkrankenhaus Soest   (Netherlands)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; ERYTHROMYCIN; LORACARBEF; PENICILLIN G;

ADULT; AGED; ARTICLE; BACILLUS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTEROIDES; BIFIDOBACTERIUM; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; ENTEROCOCCUS; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GERMANY; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MALE; MULTICENTER STUDY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPUTUM; SWEDEN; TACHYPNEA; THORAX PAIN;

BACTERIA (MICROORGANISMS); BACTEROIDES; BIFIDOBACTERIUM; CANDIDA; CLOSTRIDIUM; ENTEROCOCCUS; ESCHERICHIA COLI; LACTOBACILLUS;

EID: 0035410967     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1198-743x.2001.00264.x     Document Type: Article

References (13)

1. Community-acquired pneumonia: Diagnosis and therapy of older adults
2. Streamlining antimicrobial therapy for lower respiratory tract infections
3. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia
4. Impact of antimicrobial agents on human intestinal microflora
5. Effect of loracarbef on the normal oropharyngeal and intestinal microflora
6. Impact of loracarbef, a new oral carbacephem, on human fecal flora
7. Interindividual variability in biliary excretion of ceftriaxone: Effects on biliary lipid metabolism and on intestinal microflora
8. Influence of ceftriaxone on emergence of Clostridium difficile
9. The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract
10. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora
11. Ceftriaxone pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections
12. Treatment of various infections in an outpatient practice by intramuscular ceftriaxone: Home parenteral therapy
13. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children